NCT06694480View on ClinicalTrials.gov

Study of FID-022 in Participants With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 3, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

June 30, 2028

Conditions
Advanced Solid Tumors
Interventions
DRUG

FID-022

Advanced solid tumors

Trial Locations (1)

90033

RECRUITING

USC/Norris Comprehensive Cancer Center and Hospital, Los Angeles

Sponsors
All Listed Sponsors
lead

Fulgent Pharma LLC.

INDUSTRY